Ist bisabolene in der Schwangerschaft sicher?
No harmonised CLP classification (H360/H361) or SCCS/CIR reproductive safety assessment was found. A 2022 RIFM (peer‑reviewed) fragrance ingredient safety assessment reports insufficient toxicity data for bisabolene but uses read‑across for genotoxicity; registrant self‑classifications on ECHA dossiers list reproductive flags but these are self‑notifications and not harmonised classifications — therefore no confirmed reproductive hazard. Bisabolene is a lipophilic sesquiterpene with low water solubility, so topical absorption is low but measurable; exposure scored as 1. (Sources: RIFM safety assessment; ECHA brief profile; supplier/SDS data.)
Pregnancy-safe products containing bisabolene
Related ingredients
Frequently asked questions
- Ist bisabolene in der Schwangerschaft sicher?
- No harmonised CLP classification (H360/H361) or SCCS/CIR reproductive safety assessment was found. A 2022 RIFM (peer‑reviewed) fragrance ingredient safety assessment reports insufficient toxicity data for bisabolene but uses read‑across for genotoxicity; registrant self‑classifications on ECHA dossiers list reproductive flags but these are self‑notifications and not harmonised classifications — therefore no confirmed reproductive hazard. Bisabolene is a lipophilic sesquiterpene with low water solubility, so topical absorption is low but measurable; exposure scored as 1. (Sources: RIFM safety assessment; ECHA brief profile; supplier/SDS data.)
- Ist bisabolene während des Stillens sicher?
- No human data or harmonised classification indicating effects on lactation or breastfed infants. Mechanistic or placental/milk transfer evidence was not identified. Given topical lipophilicity and low but measurable absorption, maternal systemic exposure from cosmetic use is scored as low (1); no direct evidence of transfer in milk was found.
- Ist bisabolene sicher für Babyhaut?
- No infant‑specific toxicity data or harmonised reproductive/ developmental classification. Per instructions, adult exposure (low, 1) is increased by +1 for infant skin due to immature barrier and higher surface‑area‑to‑weight, giving e=2. No infant‑specific hazard or mechanism evidence was located.
- Wie bewertet VeriMom bisabolene?
- VeriMom bewertet bisabolene mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu bisabolene?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu bisabolene basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.
